Warning: include() [function.include]: URL file-access is disabled in the server configuration in /home/antinode/public_html/wp-content/themes/wp-medical-doctor/sidebar.php on line 67
Warning: include(http://www.linkworth.com/act/partner/code/linkad_ads.php?web_id=50291&loc_id=1&pla_id=91825&link_format=6&hash=5acb1640bc0fe77ecb396679deed017b) [function.include]: failed to open stream: no suitable wrapper could be found in /home/antinode/public_html/wp-content/themes/wp-medical-doctor/sidebar.php on line 67
Warning: include() [function.include]: Failed opening 'http://www.linkworth.com/act/partner/code/linkad_ads.php?web_id=50291&loc_id=1&pla_id=91825&link_format=6&hash=5acb1640bc0fe77ecb396679deed017b' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/antinode/public_html/wp-content/themes/wp-medical-doctor/sidebar.php on line 67
WASHINGTON (AP) — A division of Johnson & Johnson has asked federal regulators to grant full approval to an HIV drug designed to treat patients who have stopped responding to other treatments.
The Food and Drug Administration gave Intelence preliminary approval in January under its accelerated approval program, which allowed J&J to market the drug. In order to gain full approval, FDA required the company to submit follow-up data on the drug’s Read the rest of this entry »
Jessica Hooper began to cut back on her spending months ago, but last week she got serious. Shortly after Statistics Canada reported record job losses for the month of January, she realized more radical measures were needed and used the scissors on her secondary credit card.
Retailers and other service industry insiders are bracing themselves for this next wave of consumer frugality to hit as a leading trend forecaster reports that “credit card Read the rest of this entry »
(RTTNews) -
Scolr Pharma Inc. (DDD:
) announced that the U. S. Food and Drug Administration requested additional information for Abbreviated New Drug Application or ANDA for pseudoephedrine. The company noted that none of the issues cited by the FDA involve the safety or efficacy of the product.
The application seeks approval to market a 120 mg 12 hour pseudoephedrine tablet based on its patented Controlled Delivery Read the rest of this entry »
KANSAS CITY, Missouri (Reuters) – Monsanto Co said Wednesday it filed for U.S. regulatory approval for what could be the world’s first drought-tolerant corn, a product that agricultural companies around the globe are racing to roll out amid fears of global warming and the needs of a growing population.
Monsanto said it submitted its product to the U.S. Food and Drug Administration for regulatory clearance. It is working with German-based BASF on Read the rest of this entry »
Snacking on shrimp and carrot sticks, doctors and nurses gathered at
Langone Medical Center to celebrate the opening of a new research center called the Center for Healthful Behavior Change.
They were tapping into the spirit of the times, and now Gov.
has done so as well, turning the familiar call for political change into an appeal for healthful living as he promotes a number of anti-
measures, from a sugar tax on soft drinks to posting calorie Read the rest of this entry »
WASHINGTON (Reuters) – U.S. regulators are asking drugmakers to submit more details about their supply chains under a pilot program announced on Wednesday to help protect patients from fake or tainted medicines from overseas.
Companies that voluntarily provide the information can get the products through U.S. border entry points more quickly, Food and Drug Administration officials said.
Concern about imported drug ingredients grew last year after Read the rest of this entry »
Associated Press – February 6, 2009 5:05 PM ET
OKLAHOMA CITY (AP) – Attorney General Drew Edmondson says Oklahoma’s war on drugs is suffering because a source of federal funding is drying up.
Edmondson joined with attorneys general of 50 other jurisdictions this week in asking the U.S. Congress to restore federal funding to the Edward Byrne Memorial Justice Assistance Grants program.
Edmondson says Oklahoma received nearly $4.2 million in 2007, Read the rest of this entry »
WASHINGTON (AP) — A division of Johnson & Johnson has asked federal regulators to grant full approval to an HIV drug designed to treat patients who have stopped responding to other treatments.
The Food and Drug Administration gave Intelence preliminary approval in January under its accelerated approval program, which allowed J&J to market the drug. In order to gain full approval, FDA required the company to submit follow-up data on the drug’s Read the rest of this entry »
The hospital treated 17 passengers in the Sept. 12 Metrolink crash, which killed 25 people. Seventeen more patients were treated for injuries and illnesses from last month’s wildfires. But on Tuesday, Kurcz said 23 of the hospital’s 31 emergency room beds were already occupied.
“God forbid, if today was the Metrolink day, we wouldn’t be able to do that,” she said.
Already, the hospital is regularly turning away ambulances, she said. Although there Read the rest of this entry »
The state medical board is seeking to revoke the license of a former UC Santa Cruz psychotherapist who authorities say admitted to having a brief sexual relationship with a 21-year-old student whom he was treating for relationship issues and an eating disorder.
Milton Peechuan Huang, 45, of Scotts Valley, was a staff psychiatrist at the Student Health Center during the alleged affair that began in November 2007 and ended the next month, according Read the rest of this entry »